What is Halodoc?
Founded in 2016, Halodoc operates as a comprehensive mobile health application designed to bridge the gap between patients and healthcare infrastructure. By digitizing the patient journey, the platform connects millions of users with licensed medical professionals, insurance providers, and diagnostic facilities. Its market position is defined by a high-frequency, low-friction service model that includes 24/7 teleconsultation via chat, voice, or video, alongside seamless medicine procurement. As a critical player in the Indonesian digital economy, Halodoc leverages proprietary technology to optimize healthcare delivery, effectively reducing the barriers to entry for quality medical care in a fragmented market.
How much funding has Halodoc raised?
Halodoc has raised a total of $258M across 4 funding rounds:
Series A
$13M
Series B
$65M
Series C
$80M
Series D
$100M
Series A (2016): $13M with participation from Blibli, NSI Ventures, GoJek, and Clermont Group
Series B (2018): $65M led by UOB Venture Management
Series C (2021): $80M supported by Temasek and Asta International
Series D (2023): $100M featuring Pt Astra Digital Internasional
Key Investors in Halodoc
NSI Ventures
A venture capital firm specializing in early-stage technology companies in Southeast Asia, focusing on businesses with strong revenue traction and high growth potential.
UOB Venture Management
A venture capital firm that provides investment solutions to innovative companies, with a specific focus on high-growth potential businesses in the technology and digital sectors.
Temasek
A global investment company headquartered in Singapore that acts as a generational investor, focusing on long-term value creation and sustainable growth.
What's next for Halodoc?
With the successful closure of its latest funding round, Halodoc is well-positioned to accelerate its expansion strategy and deepen its technological moat. The company is expected to prioritize the enhancement of its AI-driven diagnostic tools and the further integration of its pharmacy supply chain to ensure greater service reliability. By leveraging this capital, Halodoc aims to solidify its leadership in the health-tech sector, potentially exploring new regional markets and diversifying its service offerings to include more complex chronic disease management solutions. The focus remains on achieving sustainable growth while maintaining the operational agility required to navigate the evolving regulatory and competitive landscape of digital health.
See full Halodoc company page
